Pelizzon David R sold $7.8M of KIDS (indirect holdings)
Pelizzon David R sold 336,831 indirectly-held shares of ORTHOPEDIATRICS CORP (KIDS) at an average of $23.04 ($23.04–$23.10, $7.76M total) across 2 trades over 2026-08-28 to 2026-09-01.
How this was made
The 30-second read
Why it matters
The disclosed sale may trigger short interest and influence price action in the near term.
Market read
Insider sale of $7.8M is a material event for a small‑cap, offering a modest trading cue.
What to watch
Potential upcoming capital raise or strategic transaction that prompted the insider to diversify.
Background
Form 4 filings disclose insider transactions; a director selling millions of dollars of stock is noteworthy.
Ticker impact
Director David Pelizzon sold 336,831 shares for $7.76M, reducing his stake to 6.5M shares.
Potential short-term dip of 2‑4% as market digests the sale.
Sale size is material for a small‑cap and the insider holds a significant ownership percentage.
Market effects
Minimal impact on the orthopedics sector beyond KIDS.
U.S. market only; no broader regional effect.
Low; limited to investors tracking insider activity.
Counterpoint
The sale could be a routine liquidity event, not a negative signal.
Key entities
- CompanyOrthopaedics Corp.
Ticker KIDS, provider of pediatric orthopedic devices.
- InsiderDavid R. Pelizzon
Director and 10% owner of Orthopaedics Corp.
